Congress has again averted a government shutdown through the passage of a Continuing Resolution (CR) for funding the government into early March 2024. Election year politics make bipartisanship essential to advancing key legislation in the House and Senate. The current administration will be looking to finalize program regulations and advance key administration priorities before the elections.
Global Liver Institute
GLOBAL LIVER INSTITUTE
Congress passes Continuing Resolution to extend federal funding into the new year, addresses some health care priorities
Congress temporarily averted a government shutdown through the passage of a Continuing Resolution (CR) for funding the government into early 2024, specifically through February 2, 2024.
Global Liver Institute is proud to have been an early supporter of the President’s nominee, Dr. Monica Bertagnolli, as the Director of the National Institutes of Health (NIH). After nearly 2 years since Dr. Francis Collins left the position, the Senate on a bipartisan vote has now confirmed Dr. Bertagnolli as the new NIH Director.
Congress narrowly averted a government shutdown in October and has made little progress on advancing appropriations bills needed to continue funding the government through Fiscal Year 2024.
Congress returned in September to advance appropriations bills and debate key legislative priorities, while the administration worked on policies impacting liver health by addressing disability protections in organ transplantation and with regard to the Cancer Moonshot.
Global Liver Institute Thanks President Biden for Signing the Securing the U.S. Organ Procurement and Transplantation Network Act into Law
Washington, DC, September 27, 2023 – On Friday, September 22, 2023 President Joseph Biden signed the Securing the U.S. Organ Procurement and Transplantation Network (OPTN) Act into law – which was previously passed by Congress in July.
During the Congressional recess in August, GLI prepared for a busy fall. Congress returns in September to advance appropriations bills and debate key legislative priorities.
GLI Supports NIH Naming Dr. Marrazzo as New Director of the National Institute of Allergy and Infectious Diseases
Global Liver Institute supports the selection of Jeanne M. Marrazzo, M.D., as director of the National Institute of Allergy and Infectious Diseases (NIAID) by the acting director of the NIH. Dr. Marrazzo is currently the director of the Division of Infectious Diseases at the University of Alabama at Birmingham and is a Fellow of the American College of Physicians and of the Infectious Diseases Society of America.
In July, GLI used its voice to challenge policymakers to take steps to advance high quality, equitable care for everyone.
GLI and Others Nominate Julius M. Wilder MD, PhD to National Diabetes and Digestive and Kidney Diseases Advisory Council (NDDKAC)
Global Liver Institute is pleased to nominate Julius M. Wilder MD, PhD to be a member of the NIDDK’s National Diabetes and Digestive and Kidney Diseases Advisory Council (NDDKAC).
Global Liver Institute recognizes the relationship between nonalcoholic fatty liver disease (NAFLD), its advanced form, nonalcoholic steatohepatitis (NASH), and obesity. Preventing liver disease is directly associated with treating and reducing obesity. Worldwide, NASH affects more than 148 million people and continues to become more prevalent each year.
We have so much more to do to support liver health and appreciate your consistent engagement and support in those efforts!